Prospects of a Transdermal Dosage Form (Microneedles) and Justification of the Active Substance Selection for Development of a New Medicine
Crossref DOI link: https://doi.org/10.1007/s11094-021-02541-7
Published Online: 2022-02-03
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nogaeva, U. V.
Leshkevich, A. A.
Yurochkin, D. S.
Golant, Z. M.
Flisyuk, E. V.
Ivkin, D. Yu.
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-01-01
Article History
Received: 29 July 2021
First Online: 3 February 2022